Mitozz Community Events, Webinars, and Live Q&A View Events ➝

    End of Content.

    Peer-Reviewed Papers

    Explore published research on mitochondrial function, cellular energy, (-)-epicatechin, vascular biology, and related metabolic pathways. Browse by specialization below to quickly find the papers most relevant to your interests.

    Search Papers by Specialization

    Postmenopausal Cardiovascular Risk Reduction with Epicatechin Nutraceutical

    Study Title: Improving Cardiovascular Risk in Postmenopausal Women with an (−)-Epicatechin-Based Nutraceutical: A Randomly Assigned, Double-Blind vs. Placebo, Proof-of-Concept Trial

    Citation: Garate-Carrillo et al., 2021 · Journal of Medicinal Food

    What the Study Found: In postmenopausal women, the (−)-epicatechin-based nutraceutical significantly improved multiple cardiovascular risk markers compared with placebo. It enhanced endothelial function, reduced oxidative stress, and favorably shifted lipid profiles and inflammatory markers. The changes were achieved with good tolerability over the study period.

    What this means in real life: After menopause, declining estrogen and mitochondrial efficiency in blood-vessel cells contribute to rising cardiovascular risk. This proof-of-concept trial shows that (−)-epicatechin can help restore vascular health and lower risk factors in this population. Mitochondrial support through targeted flavanols offers a practical way for women to protect heart and metabolic health during this life stage.

    Related Content

    View Paper

    Ischemia-Reperfusion Injury and Mitochondrial Protection

    Study Title: Co-administration of the flavanol (-)-epicatechin with doxycycline synergistically reduces infarct size in a model of ischemia reperfusion injury by inhibition of mitochondrial swelling

    Citation: Ortiz-Vilchis et al., 2014 · European Journal of Pharmacology

    What the Study Found: Co-administration of (−)-epicatechin and doxycycline synergistically reduced infarct size in an ischemia-reperfusion model. The protective effect was mediated by inhibition of mitochondrial swelling. The combination preserved mitochondrial structure and function during reperfusion stress.

    What this means in real life: During a heart attack, mitochondria swell and rupture, releasing signals that enlarge the damaged area. This study shows that (−)-epicatechin (especially when paired with doxycycline) powerfully prevents that swelling, limiting injury and preserving cellular energy capacity. Mitochondrial support is therefore a key strategy for protecting the heart when it faces sudden high-stress events like ischemia-reperfusion.

    Related Content

    View Paper

    The beneficial vascular effects of cacao flavanols: having your cakeand eating it too

    In this issue of the Journal of Applied Physiology, Monahan et al. (3) report on the results of a randomized, double-blind, placebo-controlled study indicating that acute cocoa ingestion dose dependently increases brachial artery flow-mediated dilation in healthy older adults. It is well known that in older individuals vascular reactivity is diminished partly due to endothelial dysfunction. Thus approaches that can restore normal endothelial reactivity if sustained over time, are likely to translate into improved cardiovascular health. The population studied (23 subjects) were of an average age of 63 yr and normotensive. The study utilized five different formulations of a low-calorie (∼100 kcal) cocoa beverage, where most of the constituents (except total polyphenol, flavan 3-ols, and procyanidins content) were held constant. As polyphenol content increased (from 330 to 1,470 mg), the concentration of suspect bioactive molecules (the flavanols catechin and epicatechin) also increased. Concentrations varied from 0 to 48 mg of catechin and 0 to 96 mg of epicatechin. In a random and blinded manner, all of the subjects were provided each of the five different formulations, thus generating responses that should be internally consistent. Beverages were only given once, thus the responses generated were of acute nature.

    View Paper

    Statins and Epicatechin: A New Angle on Cardiovascular Risk

    Study Title: Enhancement of Statin Effects on Lipid Lowering and Reduction of Cardiovascular Risk Score by (−)-Epicatechin in Proof-of-Concept Pilot Study

    Citation: Taub et al., 2025. Clinical and Translational Science

    What the Study Found: This pilot study looked at adding (−)-epicatechin to statin therapy. The combination improved lipid-related markers and reduced cardiovascular risk scores more than statins alone, suggesting a complementary effect on cardiometabolic pathways.

    What this means in real life: This study suggests that supporting cellular energy pathways may enhance how the body responds to standard cardiovascular treatments like statins. It highlights that lipid control and heart health are not just about cholesterol levels, but also about how efficiently cells manage energy and stress.

    Related Content

    View Paper

    Myocardial Infarct Size and Left Ventricular Remodeling

    Study Title: Effects of (−)-Epicatechin on Myocardial Infarct Size and Left Ventricular Remodeling After Permanent Coronary Occlusion

    Citation: Yamazaki et al., 2010 · Journal of the American College of Cardiology

    What the Study Found: (−)-Epicatechin reduced myocardial infarct size and improved left ventricular remodeling after permanent coronary occlusion. It limited adverse structural changes in the heart and preserved cardiac function in the chronic phase. The protective effects were linked to reduced oxidative stress and better mitochondrial preservation.

    What this means in real life: After a heart attack, mitochondria in surviving heart tissue are critical for preventing further remodeling and failure. This study shows that (−)-epicatechin limits infarct size and supports healthier remodeling, helping the heart maintain its energy-producing capacity long-term. Mitochondrial support is a key strategy for protecting the heart when it faces permanent damage.

    Related Content

    View Paper

    Calcium-Independent eNOS Activation via HSP90 and AKT

    Study Title: (-)-Epicatechin-induced calcium independent eNOS activation: roles of HSP90 and AKT

    Citation: Ramírez-Sánchez et al., 2012 · Molecular and Cellular Biochemistry

    What the Study Found: (−)-Epicatechin activated endothelial nitric oxide synthase (eNOS) through a calcium-independent pathway involving HSP90 and AKT signaling. It increased nitric oxide production without raising intracellular calcium levels. The mechanism was confirmed in endothelial cell models.

    What this means in real life: Endothelial mitochondria supply the energy for nitric oxide production, but they don’t always need a calcium “spark” to do it. This study shows that (−)-epicatechin can trigger eNOS through HSP90 and AKT, offering an alternative route to better blood flow. Mitochondrial support keeps these energy-dependent signaling pathways responsive and efficient.

    Related Content

    View Paper

    Cardiac Angiogenesis and Additive Effects with Exercise

    Study Title: Stimulatory effects of the flavanol (-)-epicatechin on cardiac angiogenesis: Additive effects with exercise

    Citation: Ramírez-Sánchez et al., 2012 · Journal of Cardiovascular Pharmacology

    What the Study Found: (−)-Epicatechin stimulated cardiac angiogenesis (new blood vessel formation) in the heart. When combined with exercise, the effects were additive, further enhancing vascular growth in cardiac tissue. The changes were linked to improved mitochondrial and angiogenic signaling pathways.

    What this means in real life: Healthy mitochondria power the signals that grow new blood vessels in the heart, especially when the muscle is challenged by exercise. This study shows that (−)-epicatechin boosts cardiac angiogenesis and works even better alongside physical activity. Supporting mitochondrial health helps your heart build a stronger vascular network for better oxygen delivery and long-term resilience.

    Related Content

    View Paper

    Cardiometabolic Risk Factors and Epicatechin in an Obesogenic Diet Model

    Study Title: Cardiometabolic Alterations in Wistar Rats Induced By an ObesogenicPaigen-Like Diet: Effects of (-) Epicatechin

    Citation: Gutiérrez-Salmeán et al., 2014 · Journal of Diabetes & Metabolism

    What the Study Found: An obesogenic Paigen-like diet induced multiple cardiometabolic alterations in Wistar rats. (−)-Epicatechin treatment significantly attenuated these changes, improving key markers of metabolic and cardiovascular health. The flavanol helped restore normal metabolic signaling in the model.

    What this means in real life: An unhealthy diet stresses mitochondria in the heart, liver, and blood vessels, driving inflammation and metabolic dysfunction. This study shows that (−)-epicatechin can counteract many of those diet-induced changes, protecting cellular energy pathways. Mitochondrial support helps the body stay resilient even when faced with modern dietary challenges.

    Related Content

    View Paper

    Arginase Inhibition and Cardioprotection in Ischemia/Reperfusion

    Study Title: The cardioprotective effects of (-)-Epicatechin are mediated through arginase activity inhibition in a murine model of ischemia/reperfusion

    Citation: Ortiz-Vilchis et al., 2018 · European Journal of Pharmacology

    What the Study Found: In a murine ischemia/reperfusion model, (−)-epicatechin reduced infarct size by inhibiting arginase activity. This preserved nitric oxide bioavailability, limited oxidative damage, and protected mitochondrial structure during reperfusion stress.

    What this means in real life: When a heart attack hits, mitochondria swell and rupture, expanding the damaged zone and robbing cells of energy. This study shows that (−)-epicatechin protects the heart by blocking arginase, keeping nitric oxide high and mitochondria intact. Supporting mitochondrial health is therefore a powerful way to help the heart withstand sudden stress and recover more effectively.

    Related Content

    View Paper

    Epicatechin and Heart Protection

    Study Title: Intravenous (−)-epicatechin reduces myocardial ischemic injury by protecting mitochondrial function

    Citation: Yamazaki et al., 2014. International Journal of Cardiology

    What the Study Found: This study found that intravenous (−)-epicatechin reduced myocardial infarct size in a rat ischemia-reperfusion model and helped preserve mitochondrial function during reperfusion. It was associated with improved ATP levels, reduced mitochondrial damage, and better overall cellular energy stability following cardiac injury.

    What this means in real life: This study shows that protecting mitochondrial function may play a key role in reducing damage after a cardiac event. It highlights that recovery is not just about restoring blood flow, but also about how well cells regain their ability to produce energy.

    Related Content:

    View Paper

    Epicatechin and Ischemia-Reperfusion Injury

    Study Title: (−)-Epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans

    Citation: Yamazaki et al., 2008. American Journal of Physiology-Heart and Circulatory Physiology

    What the Study Found: This study examined whether oral (−)-epicatechin pretreatment could reduce myocardial ischemia-reperfusion injury in rats. After 10 days of treatment, infarct size was significantly reduced, oxidative stress was lower, MMP-9 activity was more limited in the infarct region, and heart structure remained better preserved over time.

    What this means in real life: This study suggests that mitochondrial and tissue protection during reperfusion may be just as important as restoring blood flow itself. It reinforces the idea that reducing oxidative stress and preserving cellular function can influence how much heart damage remains after an ischemic event.

    Related Content:

    View Paper

    Cacao By-Products, Obesity, and Cardiometabolic Risk

    Study Title: Obesity and Cardiovascular Risk Improvement Using Cacao By-Products in a Diet-Induced Obesity Murine Model

    Citation: Hidalgo et al., 2019. Journal of Medicinal Food

    What the Study Found: This study tested products made from cacao by-products in a rat model of obesity induced by a high-fat diet and fructose intake. The treatments significantly reduced body weight, systolic blood pressure, triglycerides, total cholesterol, LDL cholesterol, and the triglyceride-to-HDL ratio, suggesting broad improvements in cardiometabolic risk markers.

    What this means in real life: This study suggests that cacao-derived compounds may support metabolic health beyond cocoa beans themselves, including effects on weight, blood lipids, and blood pressure. It also reinforces the idea that cardiometabolic risk is tied closely to how the body manages energy, fat storage, and vascular stress.

    Related Content:

    View Paper

    Continue Exploring Mitochondrial Science

    Mitochondria 101  |  Visit Our Blog  |  Join the Community